The JC Virus Antibody Test Goes Public

By Lisa Emrich, Health Guide Friday, February 03, 2012

- A
- A
- A

Biogen Idec was pleased to announce last week that the FDA has approved an update to the prescription labeling of the drug Tysabri (natalizumab), their monthly IV monoclonal antibody medication for MS. The prescription label now includes information regarding the increased risk of developing pr...

Read the rest of this post >>

Financial Incentives to Choose One Medication Over Another: The Nuvigil Copay Program

Hide Comments | Add comment

Debra Talley

2/ 3/12 10:23pm

I'm hopeing to test a new M.S. treatment it's not a cure but does have it's benifits!

Cathy, Health Guide

2/ 4/12 9:03am

Do tell us what it is!!!

Rebecca

2/ 5/12 10:59am

I just tested negative. What a relief since Copaxone has stopped working. It looks like a move to Tysabri until stem cells are working.

Related Multiple Sclerosis Topics

By Lisa Emrich, Health Guide— Last Modified: 03/31/12, First Published: 02/03/12

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

The JC Virus Antibody Test Goes Public

Ask a Question